Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
27 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Uchealth University of Colorado Hospital
Aurora, Colorado, United States
- Smilow Cancer Center/yale-New Haven Hospital
New Haven, Connecticut, United States
- Yale University
New Haven, Connecticut, United States
- Uf Health Cancer Institute - Gainesville
Gainesville, Florida, United States
- Emory Saint Joseph'S Hospital
Atlanta, Georgia, United States
- Emory University Hospital Midtown
Atlanta, Georgia, United States
- Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- Siteman Cancer Center at Saint Peters Hospital
City of Saint Peters, Missouri, United States
- Siteman Cancer Center at West County Hospital
Creve Coeur, Missouri, United States
- Siteman Cancer Center at Christian Hospital
St Louis, Missouri, United States
- Siteman Cancer Center-South County
St Louis, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Unc Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- University of Pittsburgh Cancer Institute (upci)
Pittsburgh, Pennsylvania, United States
- University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
- Vcu Massey Comprehensive Cancer Center
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 May 2018
- Primary completion
- 1 Dec 2026
- Completion
- 1 Dec 2026
- Last update posted
- 19 May 2026
- Registered enrollment
- 36
- Registry id
- NCT03030378
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.